Top results
âpredicting anthracycline benefit: top2a and cep17ânot only but alsoâ âpredicting anthracycline benefit: top2a and cep17ânot only but alsoâ journal of clinical oncology…
long-term outcome data for patients with her2- positive early-stage breast cancer treated with adjuvant trastuzumab: benefit outside clinical trial setting 1 meddocs publishers…
giuseppe visani1, alessandro isidori1 and giorgio minotti2 1hematology and stem cell transplant center, marche nord hospital, via lombroso, pesaro, 2center for integrated
the prediction of travel time variability in cost-benefit-analysis analysis 1 stefanie peer, [email protected] [email protected] [email protected] abstract the goal
anthracycline induced cardiomyopathy am report december 11 2009 chemotherapy and cardiotoxicity anthracyclines herceptin antimetabolites 5-fluorouracil - coronary vasospasm…
rational drug design: an information driven approach to the design of an anthracycline analoganthracycline analog master of science in biology boise state university defense
microsoft word - 12696995-file00.docxcytosol: a potential role for several promising drugs alvaro mordente, andrea silvestrini, giuseppe ettore martorana, daniela tavian,
reviewarticle anthracycline chemotherapy and cardiotoxicity john v mcgowan1 robin chung1 angshuman maulik1 izabela piotrowska1 j malcolm walker1 derek m yellon1 published…
chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways□s…
giuseppe visani1, alessandro isidori1 and giorgio minotti2 1hematology and stem cell transplant center, marche nord hospital, via lombroso, pesaro, 2center for integrated
early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapyearly- and late anthracycline-induced cardiac
rubeomycin, a new anthracycline antibiotic complex i. taxonomy of producing organism, isolation, characterization and biological activities of rubeomycin a, a1, b and b1
anthracycline-related heart failure: certain knowledge and open questionsanthracycline-related heart failure: certain knowledge and open questions where do we stand with
northwestern university feinberg school of medicine non-anthracycline adjuvant therapy: when to use? william j. gradishar md betsy bramsen professor of breast oncology director,…
336 the journal of antibiotics apr. 1978 microbial metabolism of anthracycline antibiotics daunomycin and adriamycin vincent p. marshall, j. patrick mcgovren, floyd a. richard,…
modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1� and anti-erbb2 potential mechanism for trastuzumab-induced cardiotoxicity…
nugroho prayogo dharmais cancer centerhematology & medical oncology medical faculty university of indonesia contain : 1. introduction : history adjuvant chemoth. 2. a…
powerpoint • ebctcg2012 small sized, n-ebc • predictive markers for anthracyclines her2 ihc or amplification top2 expression or alteration • t+a > a-based
powerpoint yeesoo chae, md, phd case: clinical history p/i in hospital course (i) • idc, pt1cn0mim0, g3, lvi(-), f/45, premenopause p/i in hospital course (i) •
antibiotics, doxorubicin, daunomycin and rubidazone: preferential inhibition of dna polymerase a* george p. sartiano, william e. lyncht and w. darrell bullington department